Masimo Corp (NASDAQ:MASI)
| CAPS Rating |
|
|---|---|
| Open | $21.09 |
| Previous Close | $21.81 |
| Daily Range | $20.93 - $21.54 |
| 52-Week Range | $17.62 - $35.15 |
| Market Cap | $1.28B |
| P/E Ratio | 20.20 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 843,405 |
| Average Daily Volume | 0 |
MASI
VS S&P 500 (SPY)
How do you think MASI will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MASI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MASI News and Commentary
- Masimo Earnings Preview – The Motley Fool
- How Should You Be Playing Masimo? – The Motley Fool
- Don't Get Too Worked Up Over Masimo's Latest Numbers – The Motley Fool
- Zacks Sell List Highlights: Pegasystems, Rovi, Masimo and ShangPharma - Press Releases – NASDAQ
- ROVI CORP (ROVI) - Profit Tracks – NASDAQ
- Masimo Remains Neutral - Analyst Blog – NASDAQ
- Masimo Shares Plunged: What You Need to Know – The Motley Fool
- These 2 Stocks Are Underrated – The Motley Fool
- Charlie Munger and Bad Habits – The Motley Fool
- This May Be the Next Great Growth Opportunity – The Motley Fool
- Masimo Shares Plunged: What You Need to Know – The Motley Fool
- Masimo's CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Here's Why Masimo's Latest Report Might Worry You – The Motley Fool
- Shareholder Majorities Win Major Victories – The Motley Fool
- Masimo Passes This Key Test – The Motley Fool
- Here's How Masimo May Be Failing You – The Motley Fool
- Value Ideas: Highly Profitable Stocks, Undervalued Relative to Revenue Growth – The Motley Fool
- Top 28 Low Beta Stocks With Strong Profits – SeekingAlpha
- Why Mindray Medical International's Earnings Aren't So Hot – The Motley Fool
- 3 Stocks Worthy of the Watchlist – The Motley Fool
RSS Headlines
Fool UK
